We are live on ! Find out more
ARRY

Array Biopharma Inc
ARRY

Delisted

ARRY was delisted on the 29th of July, 2019.

Back to rankings

169 hedge funds and large institutions have $1B invested in Array Biopharma Inc in 2016 Q3 according to their latest regulatory filings, with 56 funds opening new positions, 46 increasing their positions, 40 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 56 | Existing positions closed: 14

125% more capital invested

Capital invested by funds: $445M → $1B (+$556M)

67% more funds holding in top 10

Funds holding in top 10: 3 → 5 (+2)

32% more funds holding

Funds holding: 128 → 169 (+41)

15% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 40

24% less call options, than puts

Call options by funds: $8.53M | Put options by funds: $11.2M

Holders
169
Holders Change
+41
Holders Change %
+32.03%
% of All Funds
4.51%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.13%
New
56
Increased
46
Reduced
40
Closed
14
Calls
$8.53M
Puts
$11.2M
Net Calls
-$2.65M
Net Calls Change
-$3.35M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$43.9M
2
Franklin Resources
Franklin Resources
California
+$16.8M
3
Millennium Management
Millennium Management
New York
+$14.1M
4
O
OrbiMed
New York
+$12.4M
5
Invesco
Invesco
Georgia
+$7.45M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$26M
2
RG
Redmile Group
California
-$9.64M
3
BI
BVF Inc
California
-$6.96M
4
BBA
Baker Bros. Advisors
New York
-$3.87M
5
Citadel Advisors
Citadel Advisors
Florida
-$3.33M
Name Holding Trade Value Shares
Change 		Change in
Stake
PP
101
Paloma Partners
Connecticut
$432K +$248K +64,000 New
Jane Street
102
Jane Street
New York
$430K +$246K +63,653 New
NSEDCP
103
NJ State Employees Deferred Compensation Plan
New Jersey
$405K – – –
QSS
104
Quantitative Systematic Strategies
Florida
$383K +$232K +59,989 New
JG
105
Jefferies Group
New York
$346K +$198K +51,220 New
Norges Bank
106
Norges Bank
Norway
$322K +$193K +50,000 New
PAM
107
Princeton Alpha Management
New Jersey
$285K +$163K +42,193 New
DAM
108
Deltec Asset Management
New York
$270K +$155K +40,000 New
Public Employees Retirement Association of Colorado
109
Public Employees Retirement Association of Colorado
Colorado
$262K – – –
BBI
110
Baxter Bros Inc
Connecticut
$251K – – –
ICOA
111
Investment Centers of America
North Dakota
$243K – – –
PPCM
112
Pillar Pacific Capital Management
California
$241K – – –
CM
113
Crestline Management
Texas
$241K +$138K +35,715 New
BlackRock
114
BlackRock
New York
$233K +$3.28K +848 +3%
Susquehanna International Group
115
Susquehanna International Group
Pennsylvania
$206K -$1.19M -307,930 -91%
Stifel Financial
116
Stifel Financial
Missouri
$205K +$37.7K +9,745 +48%
Citigroup
117
Citigroup
New York
$203K +$32.4K +8,371 +39%
PVI
118
Pura Vida Investments
New York
$203K +$116K +30,000 New
ARTA
119
A.R.T. Advisors
New York
$196K -$920K -237,888 -89%
UBS Group
120
UBS Group
Switzerland
$195K -$202K -52,191 -64%
Commonwealth Equity Services
121
Commonwealth Equity Services
Massachusetts
$194K +$2.9K +750 +3%
EMG
122
Ellington Management Group
Connecticut
$169K +$96.7K +25,000 New
PCM
123
Palisade Capital Management
New Jersey
$148K +$85.1K +22,000 New
Legal & General Group
124
Legal & General Group
United Kingdom
$146K – – –
D.E. Shaw & Co
125
D.E. Shaw & Co
New York
$140K +$80K +20,681 New
3 4
5
6 7

ARRY Hedge Fund Activity: Q3 2016 in Review

169 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Array Biopharma Inc (ARRY) for Q3 2016, worth a combined $1B — up 125% from $445M a quarter earlier.

Buyers outnumbered sellers: 56 funds opened new ARRY positions and 14 closed out — a net gain of 42 holders — while 46 added to existing stakes and 40 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $43.9M. The largest seller was Deerfield Management, cutting an estimated $26M.

  • 169 institutional investors held Array Biopharma Inc (ARRY) as of Q3 2016, up from 128 in Q2 2016.
  • Funds reported $1B of Array Biopharma Inc stock for Q3 2016, up 125% quarter-over-quarter.
  • 56 funds opened new Array Biopharma Inc positions in Q3 2016 and 14 closed out, a net change of +42 holders.
  • The largest Array Biopharma Inc buyer in Q3 2016 was Fidelity Investments, an estimated $43.9M added.
  • The largest Array Biopharma Inc seller in Q3 2016 was Deerfield Management, an estimated $26M sold.

Based on aggregated 13F filings for Q3 2016.